A B Anderson

No ORCID on file · 8 papers in corpus
other 1984
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem-58-5-813

Endometria and myometria were collected at hysterectomy from 42 women with measured menstrual blood loss. Specimens were obtained throughout the menstrual cycle [menstrual (n = 11), follicular (n = 9), early luteal (n = 6), midluteal (n = 9…

observational 1984
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1984.tb04829.x

Menstrual fluid was collected in vaginal cups inserted for 2 h during the first 2 days of menstruation and menstrual serum concentrations of prostaglandins PGF2 alpha and PGE2 were measured by radioimmunoassay. In 16 women from whom menstru…

other 1981
The Practitioner
nonrandomized-trial 1980
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1980.tb04550.x

In 13 ovulatory women with objective evidence of menorrhagia (menstrual blood loss greater than 80 ml), danazol 400 mg given daily for 12 weeks suppressed ovulation as shown by absence of gonadotrophin peaks, low serum progesterone levels a…

nonrandomized-trial 1980
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1980.tb04489.x

In women with menorrhagia of unknown cause, the efficacy of the drug danazol in reducing heavy menstrual blood loss was investigated making objective measurements of menstrual blood loss. Drug regimens tested were daily administration of 20…

nonrandomized-trial 1980
International Journal of Gynecology & Obstetrics ·doi:10.1002/j.1879-3479.1980.tb00209.x

Twenty-two women with unexplained heavy menstrual blood loss (average loss for two cycles of >80 ml) were treated with the prostaglandin synthetase inhibitor menfenamic acid during two consecutive menstruations. There was a significant redu…

nonrandomized-trial 1979
Postgraduate medical journal

Preliminary results are presented on the effect of 400, 200 and 100 mg of daily danazol on measured menstrual blood loss, in women with menorrhagia. Both 400 and 200 mg daily effectively suppressed menstrual blood loss, 400 mg reducing mens…

nonrandomized-trial 1979
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1979.tb10683.x

Eighteen patients with objective evidence of menorrhagia (more than 80 ml menstrual blood loss) were treated with danazol for twelve weeks. Danazol significantly reduced the menstrual blood loss from 231 +/- 39 ml (mean +/- SEM) to 135 +/- …